INTERACTION OF POLYCLONAL HUMAN IGE WITH PROTEIN-A FROM STAPHYLOCOCCUS AUREUSJOHANSSON SGO; INGANAS M.1978; IMMUNOL. REV.; DNK; DA. 1978; VOL. 41; PP. 248-260; BIBL. 1 P.Article

DETECTION OF FC RECEPTOR-BEARING LYMPHOCYTES BY USING IGG-COATED LATEX PARTICLESSJOBERG O; INGANAS M.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 6; PP. 547-552; BIBL. 17 REF.Article

INTESTINAL UPTAKE OF OVALBUMIN IN MALABSORPTION AND FOOD ALLERGY IN RELATION TO SERUM IGG ANTIBODY AND ORALLY ADMINISTERED SODIUM CROMOGLYCATEDANNAEUS A; INGANAS M; JOHANSSON SGO et al.1979; CLIN. ALLERGY; GBR; DA. 1979; VOL. 9; NO 3; PP. 263-270; BIBL. 13 REF.Article

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumorsNORBERG, T; LENNERSTRAND, J; INGANAS, M et al.International journal of cancer. 1998, Vol 79, Num 4, pp 376-383, issn 0020-7136Article

Detection of IgG4 antibodies by immunoblotting in patients on vespid venom immunotherapyEINARSSON, R; INGANAS, M; KARLSSON, T et al.Journal of immunological methods. 1989, Vol 120, Num 2, pp 265-269, issn 0022-1759Article

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insADØRUM, A; HOVIG, E; TROPE, C et al.European journal of cancer (1990). 1999, Vol 35, Num 5, pp 779-781, issn 0959-8049Article

Recombinant protein A of non-staphylococcal origin is not mitogenic for human peripheral lymphocytes: mitogenicity of natural protein A is caused by a contaminantPERSSON, U; INGANAS, M; SMITH, C. I. E et al.Scandinavian journal of immunology (Print). 1989, Vol 29, Num 2, pp 151-158, issn 0300-9475Article

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markersSJÖGREN, S; INGANÄS, M; LINDGREN, A et al.Journal of clinical oncology. 1998, Vol 16, Num 2, pp 462-469, issn 0732-183XArticle

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancerDØRUM, A; HEIMDAL, K; HOVIG, E et al.American journal of human genetics. 1999, Vol 65, Num 3, pp 671-679, issn 0002-9297Article

The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune responseRIVERA, E; PETTERSSON, F. Ekholm; INGANÄS, M et al.Vaccine. 2005, Vol 23, Num 46-47, pp 5411-5419, issn 0264-410X, 9 p.Article

Prognostic value of p53 genetic changes in colorectal cancerKRESSNER, U; INGANÄS, M; BYDING, S et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 593-599, issn 0732-183XArticle

Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanomaPLATZ, A; RINGBORG, U; LAGERLÖF, B et al.British journal of cancer. 1996, Vol 73, Num 3, pp 344-348, issn 0007-0920Article

Complete sequence of p53 gene in 20 patients with lung cancer : comparison with chemosensitivity and immunohistochemistryBRATTSTRÖM, D; BERGQVIST, M; LAMBERG, K et al.Medical oncology (Northwood). 1998, Vol 15, Num 4, pp 255-261, issn 1357-0560Article

Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanomaPLATZ, A; HANSSON, J; MANSSON-BRAHME, E et al.Journal of the National Cancer Institute. 1997, Vol 89, Num 10, pp 697-702, issn 0027-8874Article

Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patientsFALETTE, N; PAPERIN, M.-P; OZTURK, M et al.Cancer research (Baltimore). 1998, Vol 58, Num 7, pp 1451-1455, issn 0008-5472Article

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerBERNS, E. M. J. J; FOEKENS, J. A; CORNELISSE, C et al.Cancer research (Baltimore). 2000, Vol 60, Num 8, pp 2155-2162, issn 0008-5472Article